Affiliation:
1. 1Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, U.K.
2. 2Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, U.K.
3. 3Centre for Diabetes, Endocrinology, and Metabolism, Birmingham Health Partners, Birmingham, U.K.
Abstract
Abstract
The ovaries are key steroid hormone production sites in post-pubertal females. However, current research on steroidogenic enzymes, endogenous hormone concentrations and their effects on healthy ovarian function and malignant development is limited. Here, we discuss the importance of steroid enzymes in normal and malignant ovaries, alongside hormone concentrations, receptor expression and action. Key enzymes include STS, 3β-HSD2, HSD17B1, ARK1C3, and aromatase, which influence ovarian steroidal action. Both androgen and oestrogen action, via their facilitating enzyme, drives ovarian follicle activation, development and maturation in healthy ovarian tissue. In ovarian cancer, some data suggest STS and oestrogen receptor α may be linked to aggressive forms, while various oestrogen-responsive factors may be involved in ovarian cancer metastasis. In contrast, androgen receptor expression and action vary across ovarian cancer subtypes. For future studies investigating steroidogenesis and steroidal activity in ovarian cancer, it is necessary to differentiate between disease subtypes for a comprehensive understanding.
Funder
The Eve Appeal
Birmingham Women's Charitable Funds